The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| AFFIMED N V | COM | N01045108 | 1,521 | 347,965 | SH | SOLE | 347,965 | 0 | 0 | ||
| AKOUOS INC | COM | 00973J101 | 1,842 | 387,892 | SH | SOLE | 387,892 | 0 | 0 | ||
| AMARIN CORP PLC | SPONS ADR NEW | 023111206 | 7,548 | 2,294,082 | SH | SOLE | 2,294,082 | 0 | 0 | ||
| AMICUS THERAPEUTICS INC | COM | 03152W109 | 5,431 | 573,516 | SH | SOLE | 573,516 | 0 | 0 | ||
| BIOGEN INC | COM | 09062X103 | 8,053 | 38,236 | SH | SOLE | 38,236 | 0 | 0 | ||
| BURNING ROCK BIOTECH LTD | SPONSORED ADS | 12233L107 | 7,182 | 773,114 | SH | SOLE | 773,114 | 0 | 0 | ||
| CABALETTA BIO INC | COM | 12674W109 | 1,251 | 616,125 | SH | SOLE | 616,125 | 0 | 0 | ||
| CATALYST BIOSCIENCES INC | COM NEW | 14888D208 | 70 | 106,089 | SH | SOLE | 106,089 | 0 | 0 | ||
| CELLDEX THERAPEUTICS INC NEW | COM NEW | 15117B202 | 25,648 | 753,034 | SH | SOLE | 753,034 | 0 | 0 | ||
| CENTESSA PHARMACEUTICALS PLC | SPONSORED ADS | 152309100 | 6,002 | 669,100 | SH | SOLE | 669,100 | 0 | 0 | ||
| CONNECT BIOPHARMA HLDGS LTD | ADS | 207523101 | 688 | 227,759 | SH | SOLE | 227,759 | 0 | 0 | ||
| FATE THERAPEUTICS INC | COM | 31189P102 | 3,541 | 91,337 | SH | SOLE | 91,337 | 0 | 0 | ||
| GLOBAL BLOOD THERAPEUTICS IN | COM | 37890U108 | 46,394 | 1,339,322 | SH | SOLE | 1,339,322 | 0 | 0 | ||
| GOSSAMER BIO INC | COM | 38341P102 | 15,908 | 1,832,704 | SH | SOLE | 1,832,704 | 0 | 0 | ||
| KRYSTAL BIOTECH INC | COM | 501147102 | 1,224 | 18,393 | SH | SOLE | 18,393 | 0 | 0 | ||
| LIQUIDIA CORPORATION | COM NEW | 53635D202 | 8,326 | 1,159,674 | SH | SOLE | 1,159,674 | 0 | 0 | ||
| MERUS N V | COM | N5749R100 | 3,087 | 116,764 | SH | SOLE | 116,764 | 0 | 0 | ||
| NATERA INC | COM | 632307104 | 39,313 | 966,400 | SH | SOLE | 966,400 | 0 | 0 | ||
| NEKTAR THERAPEUTICS | COM | 640268108 | 260 | 200,000 | SH | Put | SOLE | 200,000 | 0 | 0 | |
| NEOLEUKIN THERAPEUTICS INC | COM | 64049K104 | 264 | 140,508 | SH | SOLE | 140,508 | 0 | 0 | ||
| OLEMA PHARMACEUTICALS INC | COM | 68062P106 | 1,196 | 280,827 | SH | SOLE | 280,827 | 0 | 0 | ||
| PUMA BIOTECHNOLOGY INC | COM | 74587V107 | 1,882 | 653,445 | SH | SOLE | 653,445 | 0 | 0 | ||
| RADIUS HEALTH INC | COM NEW | 750469207 | 1,638 | 185,514 | SH | SOLE | 185,514 | 0 | 0 | ||
| SERES THERAPEUTICS INC | COM | 81750R102 | 2,075 | 291,443 | SH | SOLE | 291,443 | 0 | 0 | ||
| SIERRA ONCOLOGY INC | COM NEW | 82640U404 | 6,195 | 193,280 | SH | SOLE | 193,280 | 0 | 0 | ||
| SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | 33,592 | 1,932,800 | SH | SOLE | 1,932,800 | 0 | 0 | ||
| TG THERAPEUTICS INC | COM | 88322Q108 | 401 | 258,600 | SH | Put | SOLE | 258,600 | 0 | 0 | |
| TRAVERE THERAPEUTICS INC | COM | 89422G107 | 22,444 | 870,918 | SH | SOLE | 870,918 | 0 | 0 | ||
| VAXCYTE INC | COM | 92243G108 | 13,998 | 579,640 | SH | SOLE | 579,640 | 0 | 0 | ||
| VERA THERAPEUTICS INC | CL A | 92337R101 | 11,800 | 502,328 | SH | SOLE | 502,328 | 0 | 0 | ||
| VIRIDIAN THERAPEUTICS INC | COM | 92790C104 | 10,906 | 589,826 | SH | SOLE | 589,826 | 0 | 0 | ||
| WAVE LIFE SCIENCES LTD | SHS | Y95308105 | 3,823 | 1,911,728 | SH | SOLE | 1,911,728 | 0 | 0 | ||
| XENON PHARMACEUTICALS INC | COM | 98420N105 | 14,774 | 483,270 | SH | SOLE | 483,270 | 0 | 0 | ||